Around 780,000 rare disease cases have been registered in China since the inception of a rare disease diagnosis and treatment service information system in 2019. The country's rare disease catalog now includes 207 conditions, including spinal muscular atrophy (SMA). In recent years, China has slashed the prices of rare disease drugs through measures such as adjusting the medical insurance catalog, making life-saving medications accessible to rare disease patients who are in dire need.